These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 21407190)
1. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190 [TBL] [Abstract][Full Text] [Related]
2. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis. Ford AC; Khan KJ; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106 [TBL] [Abstract][Full Text] [Related]
3. Aminosalicylates for induction of remission or response in Crohn's disease. Lim WC; Wang Y; MacDonald JK; Hanauer S Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735 [TBL] [Abstract][Full Text] [Related]
4. Aminosalicylates for induction of remission or response in Crohn's disease. Lim WC; Hanauer S Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400 [TBL] [Abstract][Full Text] [Related]
5. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Gordon M; Taylor K; Akobeng AK; Thomas AG Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188 [TBL] [Abstract][Full Text] [Related]
7. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875 [TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Derwa Y; Gracie DJ; Hamlin PJ; Ford AC Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis. Ford AC; Khan KJ; Achkar JP; Moayyedi P Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446 [TBL] [Abstract][Full Text] [Related]
10. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Gordon M; Naidoo K; Thomas AG; Akobeng AK Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183 [TBL] [Abstract][Full Text] [Related]
13. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Khan KJ; Ullman TA; Ford AC; Abreu MT; Abadir A; Marshall JK; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):661-73. PubMed ID: 21407187 [TBL] [Abstract][Full Text] [Related]
14. Interventions for prevention of post-operative recurrence of Crohn's disease. Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis. Ford AC; Khan KJ; Sandborn WJ; Hanauer SB; Moayyedi P Clin Gastroenterol Hepatol; 2012 May; 10(5):513-9. PubMed ID: 22083024 [TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Akobeng AK; Gardener E Cochrane Database Syst Rev; 2005 Jan; (1):CD003715. PubMed ID: 15674913 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis. Coward S; Kuenzig ME; Hazlewood G; Clement F; McBrien K; Holmes R; Panaccione R; Ghosh S; Seow CH; Rezaie A; Kaplan GG Inflamm Bowel Dis; 2017 Mar; 23(3):461-472. PubMed ID: 28146003 [TBL] [Abstract][Full Text] [Related]
19. [5-aminosalicylic acid for induction of remission or clinical response in Crohn's disease--a survey of a Cochrane review]. Bjerrum JT; Munck LK; Nielsen OH Ugeskr Laeger; 2011 Aug; 173(35):2110-3. PubMed ID: 21884660 [TBL] [Abstract][Full Text] [Related]
20. Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis. Ford AC; Khan KJ; Sandborn WJ; Kane SV; Moayyedi P Am J Gastroenterol; 2011 Dec; 106(12):2070-7; quiz 2078. PubMed ID: 21894226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]